SU, CHING-HUA,苏庆华,蘇慶華,TAI, CHENG-JENG,戴承正,戴承正,SHI, YEU-CHING,时雨青,時雨青
申请号：
TW105115737
公开号：
TW201740966A
申请日:
2016.05.20
申请国别(地区):
TW
年份:
2017
代理人:
摘要：
The present invention provides a pharmaceutical composition for adjunctively treating cancer. Differing from conventional therapy using anti-cancer drugs and radiation substances to cause the apoptosis of cancer cells, the present invention takes an ethanol extract ofTaiwanofunguscamphoratus(TCEE), an ethanol extract ofGanodermalucidum(GLEE) or a combination of the TCEE and the GLEE as the pharmaceutical composition, which is able to cause the apoptosis occurring on lung cancer cells A594, hepatoma cells Huh 7, breast cancer cells MDA-MB 231, and colorectal cancer cells HT 29. Moreover, differing from conventionally-used anti-cancer drugs and radiation substances always causing some side-effects such as nausea, vomit, and appetite loss, this novel pharmaceutical composition can not only be used for adjunctively treating cancer, but also possesses others healthy effects, including: detoxification, enhancing immunity, and increasing appetite.本發明係提供一種用於輔助治療癌症的醫藥組合物。不同於習知技術係以抗癌藥或放射線物質來達成致死癌細胞的效果,本發明係以牛樟芝酒萃物、靈芝酒萃物、或靈樟芝酒萃物作為新穎的醫藥組合物,以達成致死肺癌細胞A549、肝癌細胞Huh7、乳癌細胞MDA-MB 231、以及大腸癌細胞HT 29的醫療功效。此外,相較於習用的抗癌藥或放射線物質多具有導致患者噁心、嘔吐、食欲不振等副作用,本發明之牛樟芝酒萃物、靈芝酒萃物、或靈樟芝酒萃物除了可以達到致死癌細胞的功效外,同時還具有清熱解毒、增強免疫力作用、增加食慾之功效。
